|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61P 11/12 | (2006.01) | ||
| A61K 31/4985 | (2006.01) |
| (11) | Patento numeris | 3544981 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17807900.0 |
| Europos patento paraiškos padavimo data | 2017-11-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2017/053499 |
| Data | 2017-11-22 |
| (87) | Numeris | WO 2018/096325 |
| Data | 2018-05-31 |
| (30) | Numeris | Data | Šalis |
| 201619694 | 2016-11-22 | GB |
| (72) |
MCCARTHY, Clive , GB
HARGRAVE, Jonathan, David , GB
HAY, Duncan, Alexander , GB
SCHOFIELD, Thomas, Beauregard , GB
WENT, Naomi , GB
|
| (73) |
Enterprise Therapeutics Limited ,
Sussex Innovation Centre
University of Sussex
Science Park Square, Falmer, Brighton BN1 9SB,
GB
|
| (54) | BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS |
| BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS |